1 / 32

Management of periampullary tumor What are the options for ampullary adenoma?

Joint Hospital Surgical Grand Round (July 2017) Presented by Dr. Sin Kar Yan, PMH. Management of periampullary tumor What are the options for ampullary adenoma?. Case Study. Miss Wong F/64 Hepatitis B carrier Asymptomatic patient OGD for screening for varices No varices

lorettaking
Download Presentation

Management of periampullary tumor What are the options for ampullary adenoma?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Joint Hospital Surgical Grand Round (July 2017) Presented by Dr. Sin Kar Yan, PMH Management of periampullary tumorWhat are the options for ampullary adenoma?

  2. Case Study • Miss Wong • F/64 • Hepatitis B carrier • Asymptomatic patient • OGD for screening for varices • No varices • Incidental finding of ampulla mass 4x2cm

  3. Case Study • Biopsy: Tubular adenoma • Hb normal • LFT normal • Referral to surgery What to do next?

  4. Introduction Periampullary tumors • Neoplasms that arise within 2cm of the ampulla of Vater • Origins • Pancreas • Distal CBD • Ampulla • Duodenum Image: Netter, Frank Henry, and Sharon Colacino. Atlas of human anatomy. Ciba-Geigy Corporation, 1989.

  5. Differential Diagnosis • Benign • Tubular adenoma, tubulovillous or villous adenoma • Prevalence: 0.04% to 0.12% • Rate of transformation to carcinoma: 30% • Hemangioma • Leiomyoma • Leiomyofibroma • Lipoma • Lymphangioma • Neuroendocrine tumor • Malignant (>90%) • Adenocarcinoma Baker HL, Caldwell DW. Lesions of the ampulla of Vater. Surgery. 1947;21:523–531. Sato T, Konishi K, Kimura H, Maeda K, Yabushita K, Tsuji M, Miwa A. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA. Hepatogastroenterology. 1999;46:1959–1962. Seifert, Erwin, Ferdinand Schulte, and Manfred Stolte. "Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study." American Journal of Gastroenterology 87.1 (1992).

  6. Presentations of Periampullary Tumors • Asymptomatic as incidental finding • Symptomatic • Jaundice • Abdominal pain • Palpable gallbladder • Acute pancreatitis • UGIB / obstruction

  7. Investigations • Blood investigations • Complete blood count • Liver function test • CA 19.9 • Imaging and endoscopy • Ultrasound • CT • MRCP • Duodenoscopy • ERCP • EUS

  8. Duodenoscopy / ERCP • Visualization of ampulla • Assessment of biliary system • ± biliary drainage if obstruction • Benign and malignant ampullary tumors may not be distinguished on appearance alone Malignant Benign

  9. Duodenoscopy / ERCP • Characteristics of malignant lesions • Induration / rigidity • Ulceration • Suspicious lesions should be biopsied before endoscopic resection • False negative rate up to 30% Yamaguchi, Koji, Munetomo Enjoji, and Katsutoshi Kitamura. "Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors." Gastrointestinal endoscopy 36.6 (1990): 588-592.

  10. Endoscopic Ultrasound • Identify small lesions • Assess intraductal extension and extension beyond muscularis propia • Obtain tumor biopsy • Assess lymph node status + biopsy Adler, Douglas G., et al. "The role of endoscopy in ampullary and duodenal adenomas." Gastrointestinal endoscopy 64.6 (2006): 849-854. Onkendi, Edwin O., et al. "Adenomas of the ampulla of Vater: a comparison of outcomes of operative and endoscopic resections." Journal of Gastrointestinal Surgery 18.9 (2014): 1588-1596.

  11. Endoscopic Ultrasound • Who should undergo EUS? • No consensus • Lesions >1cm • Lesions with suspicion of malignancy

  12. Narrow Band Imaging • Imaging features • Irregular villous arrangement • Irregular villous size • Disappearance of ridges • Demarcation of normal villi • Abnormal microvasculatures

  13. Narrow Band Imaging • Features of irregular villous arrangement + abnormal microvasculatures • Diagnose adenocarcinoma with a sensitivity of 69% and specificity of 100% Park, Jin-Seok, et al. "Usefulness of white-light imaging–guided narrow-band imaging for the differential diagnosis of small ampullary lesions." Gastrointestinal endoscopy 82.1 (2015): 94-101.

  14. Narrow Band Imaging • Guide target biopsy site • Not suitable as a screening tool due to the low sensitivity • Role of NBI is still being investigated • Large scale prospective study is required

  15. Treatment: Ampullectomy

  16. Ampullectomy Surgical ampullectomy • Transduodenal local excision • Involves reimplantation of the distal CBD and pancreatic duct within the duodenal wall Endoscopic ampullectomy • “papillectomy” • Resection of mucosa and submucosa of the duodenal wall, in the area of the anatomical attachments of the ampulla of Vater, including the tissue around the bile duct and the pancreatic-duct orifices

  17. Surgical Ampullectomy • Classic treatment for ampullary adenoma Schneider, Lutz, et al. "Surgical ampullectomy: an underestimated operation in the era of endoscopy." HPB: the official journal of the International Hepato Pancreato Biliary Association 18.1 (2016): 65.

  18. Surgical Ampullectomy Duodenotomy with ampullary adenoma exposed Reimplantation of CBD and PD Ángel, José Manuel Ramia, et al. "Ampulectomía transduodenal como tratamiento del adenoma de ampolla de Vater." Cirugía Española 87.3 (2010): 184-185.

  19. Surgical Ampullectomy • Frozen section can be performed • Conversion to radical pancreaticoduodenectomy if malignancy is found • Mortality 0-3% • Morbidity 42-45% • Complications • Bleeding • Cholangitis / pancreatitis • Anastomotic / duodenal leakage • Papillary stenosis Ceppa, Eugene P., et al. "Endoscopic versus surgical ampullectomy: an algorithm to treat disease of the ampulla of Vater." Annals of surgery 257.2 (2013): 315-322. Grobmyer, Stephen R., et al. "Contemporary results with ampullectomy for 29 “benign” neoplasms of the ampulla." Journal of the American College of Surgeons 206.3 (2008): 466-471.

  20. Endoscopic Ampullectomy • “papillectomy” • Minimally invasive • En bloc resection for small lesions • Piecemeal resection for large lesions may be required Image: Bassan, Milan, and Michael Bourke. "Endoscopic ampullectomy: a practical guide." Journal of interventional gastroenterology 2.1 (2012): 23.

  21. Endoscopic Ampullectomy • Patient selection • Lesion <4-5cm • Histology • Benign • High grade dysplasia is not a contraindication • EUS criteria • No invasion of duodenal muscularis propia • No tumor growth beyond 1cm inside CBD / pancreatic duct • Positive lifting sign

  22. Endoscopic Ampullectomy De Palma, Giovanni D. "Endoscopic papillectomy: indications, techniques, and results." World Journal of Gastroenterology: WJG 20.6 (2014): 1537.

  23. Endoscopic Ampullectomy • Techniques • Submucosal injection • Lift sign • Endoscopic snare and electrocautery • En bloc resection for small lesions • Piecemeal resection or multiple procedures may be required for larger lesions • Electrocautery injuries to tissue fragments can affect pathological analysis • Ablation (Argon plasma coagulation) if any residual lesion • Sphincterotomy • Helps pancreaticobiliary drainage after papillectomy • Stent placement • Not routine • Aim to prevent iatrogenic pancreatitis

  24. Endoscopic Ampullectomy • Multiple sessions may be required • Mortality 0% • Morbidity 18% • Complications • Early: Pancreatitis, cholangitis, bleeding, perforation • Late: Papillary stenosis • Post-ampullectomy surveillance endoscopy required • 3-12months for at least 2 years • More frequently in case of high grade dysplasia Ceppa, Eugene P., et al. "Endoscopic versus surgical ampullectomy: an algorithm to treat disease of the ampulla of Vater." Annals of surgery 257.2 (2013): 315-322.

  25. EA vs SA • Endoscopic ampullectomy (EA) is superior to surgical ampullectomy (SA) in terms of: • Morbidity (18 vs 42%) • Length of stay (0.6 vs 10.1days) • Readmission rate (16 vs 34%) Ceppa, Eugene P., et al. "Endoscopic versus surgical ampullectomy: an algorithm to treat disease of the ampulla of Vater." Annals of surgery 257.2 (2013): 315-322.

  26. EA vs SA • Positive margin and recurrence rate for EA are higher than SA • 20 vs 10% (no statistical significance) • Re-intervention rate for EA is higher than SA • 26% vs 15% (no statistical significance) • EA: mainly for margin re-excision • SA: mainly for complications Ceppa, Eugene P., et al. "Endoscopic versus surgical ampullectomy: an algorithm to treat disease of the ampulla of Vater." Annals of surgery 257.2 (2013): 315-322.

  27. EA vs SA • Endoscopic ampullectomy is preferred • Surgical ampullectomy for lesions not feasible for endoscopic treatment

  28. Back to our patient… • EUS + endoscopic ampullectomy done • 4.5cm lateral spreading ampulla tumor • No intraductal extension • Ampullectomy performed • CBD stent and pancreatic ductal stent inserted

  29. Submucosal injection Post-ampullectomy Ampullar tumor 45mm x 20mm

  30. Back to our patient… • Post-operative course was uneventful • Diet was resumed on the next day • No fever • LFT normal • Discharge home on day 4 • Pathology: • Tubulovillous adenoma with low grade dysplasia • Lateral margin clear • Plan for surveillance endoscopy 3 months later

  31. Conclusions • Ampullary adenomas are rare • EUS has an important role in management decision • NBI may help improve diagnostic accuracy • More study would be needed to assess its efficacy • Endoscopic ampullectomy is a more favorable option than surgical ampullectomy • Minimally invasive, avoid GA • Lower morbidity • But the positive margin and recurrence rates are higher • Surgical ampullectomy • Treatment choice when EA is not feasible

  32. The End

More Related